- CIIX CEO Warren Wang and CBD Biotech executives attended 2019 China Industrial Cannabis CBD Industry International Conference
- At well over one billion people, China’s cannabis industry market potential is four times the size of America’s
- CEO responds to stock’s fluctuating volatility, urges shareholders to continue to invest
ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading purveyor of financial information and education for Chinese-speaking investors in the United States and China providing real-time market commentary, analysis, and educational-related services in Chinese character language sets. The products and services offered help investors make informed decisions and meet individualized financial goals. After creating inroads into the lucrative cannabis sector in the United States through its subsidiary CBD Biotech Inc., CIIX is leveraging its own financial expertise to establish itself as a leader in China’s emerging CBD industry.
On November 23-24, CBD Biotech executives attended the 2019 China Industrial Cannabis CBD Industry International Conference in Haerbing, China. Warren Wang, CEO of CIIX, joined Donald Baillargeon on MoneyTV to share highlights from the conference and recent company news.
Wang described the conference’s focus on the hemp/CBD industry in China, which cemented his belief that the industry has a bright future. China’s cannabis industry is in the early stage of development and has a large potential for growth. Institutional investors, analysts, and fund managers who are interested in the opportunities both in China and offshore were in attendance. Legalizations is slow in China, but the laws are changing, and investors are looking for potential opportunities. With approximately 1.4 billion people, China has four times the market potential of America. In a Wall Street Journal video, titled ‘Why China is Betting Big on CBD’ (http://ibn.fm/UwOFI), the consensus among Chinese entrepreneurs is that while the U.S. is a currently a major player, the future of the cannabis industry belongs to China.
CBD Biotech executives were on hand at November’s conference to feature new products and provide information and education on current products. The company is one of the first to enter this market and has laid the foundation for success as the hemp/CBD industry continues to grow in China (http://ibn.fm/2RjQj).
In the MoneyTV interview with Baillargeon, Wang also responded to CIIX stock’s fluctuating volatility, speaking to the company’s strong management team and focused achievement of long-term objectives. He reminded shareholders of Amazon’s early days where the value of stocks would fluctuate dramatically. Since CIIX is still a young company and has a promising future, Wang commented that “short term stock volatility is not going to effect the long-term picture.” For now, he encourages those who believe in CIIX to invest disposable money.
The strength of CIIX lies in its management team, long-term goals and strategy, and placement in a potentially explosive market.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
